title: Bortezomib: understanding the mechanism of action.
authors.affiliation: Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA. bpiperdi@montefiore.org
authors.forename: Bilal
authors.initials: B
authors.lastname: Piperdi
authors.forename: Yi-He
authors.initials: YH
authors.lastname: Ling
authors.forename: Leonard
authors.initials: L
authors.lastname: Liebes
authors.forename: Franco
authors.initials: F
authors.lastname: Muggia
authors.forename: Roman
authors.initials: R
authors.lastname: Perez-Soler
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis; D001897:Boronic Acids / Q000494:pharmacology*; D006801:Humans; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors*; D011480:Protease Inhibitors / Q000494:pharmacology*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D011719:Pyrazines / Q000494:pharmacology*; D014108:Tosylphenylalanyl Chloromethyl Ketone / Q000031:analogs & derivatives*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D009097:Multienzyme Complexes; D011480:Protease Inhibitors; D019253:Proto-Oncogene Proteins c-bcl-2; D011719:Pyrazines; D014108:Tosylphenylalanyl Chloromethyl Ketone